GlassScriptPhysician profile
Fiorella Rocca
NPI 1588319685
$8,244.80
in general payments reported to CMS, 2019-2025
37 companies · $1,771 in 2025
The $1,771 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,549 · 2023: $2,908 · 2024: $2,017 · 2025: $1,771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,696.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,700.22 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $1,029.09 | 2022-2025 | |
| Novo Nordisk INC | $817.24 | 2022-2025 | Ozempic, Rybelsus, Tresiba |
| Bayer Healthcare Pharmaceuticals INC. | $482.34 | 2023-2025 | |
| Lilly USA, LLC | $477.73 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $449.11 | 2022-2025 | Jardiance, Synjardy, Spiriva |
| Pfizer INC. | $355.25 | 2022-2025 | |
| Astellas Pharma US INC | $345.26 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $341.21 | 2023-2025 | Aptima, Thinprep 2000 Processor |
| Merck Sharp & Dohme LLC | $340.90 | 2022-2025 | Verquvo, Belsomra, Steglatro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $306.60 | 2023-2025 | Xifaxan |
| Amgen INC. | $283.99 | 2023-2025 | Repatha, Otezla, Repatha |
| Dexcom, INC. | $151.95 | 2024-2025 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $147.80 | 2024-2025 | Voquezna |
| Abbott Laboratories | $120.96 | 2023 | Freestyle Libre 3 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fiorella Rocca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.